LFMDP - LifeMD Appoints Dr. Calum MacRae to its Board of Directors | Benzinga
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors.
"We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services," said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. "Aside from being a world-renowned clinician, we are particularly excited to leverage Dr. MacRae's experience with systematic approaches to the management of chronic disease, which includes leveraging novel in-home tools and labs that can transform the way chronic and preventative care are delivered."
"I am impressed by LifeMD's strategy and track record of providing innovative and ...